Search Count: 3
All
Selected
 |
Structure Of Chk1 10-Pt. Mutant Complex With Macrocyclic Lrrk2 Inhibitor Compound 1 ((11R)-8-Chloro-3,11-Dimethyl-2-(Oxan-4-Yl)-2,4,10,11,12,13-Hexahydro-9,5-(Azeno)Pyrazolo[3,4-B][1,4,6,10]Oxatriazacyclotridecine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2026-04-08 Classification: TRANSFERASE/INHIBITOR Ligands: A1C5F |
 |
Structure Of Chk1 10-Pt. Mutant Complex With Macrocyclic Lrrk2 Inhibitor Compound 7 ((10As,13As)-3-Cyclobutyl-1-Methyl-8-(Trifluoromethyl)-3,4,10A,11,13A,14-Hexahydro-10H,13H-9,5-(Azeno)Furo[3,4-K]Pyrazolo[4,3-B][1,4,6,10]Oxatriazacyclotridecine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2026-04-08 Classification: TRANSFERASE/INHIBITOR Ligands: A1C5G |
 |
Structure Of Chk1 10-Pt. Mutant Complex With Macrocyclic Lrrk2 Inhibitor Compound 12 ((10As,13As)-3-Cyclopropyl-1-Methyl-8-(Trifluoromethyl)-3,4,10A,11,13A,14-Hexahydro-10H,13H-9,5-(Azeno)Furo[3,4-K]Pyrazolo[4,3-B][1,4,6,10]Oxatriazacyclotridecine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2026-04-08 Classification: TRANSFERASE/INHIBITOR Ligands: A1C5H |